Curis to Present at Upcoming Investor Conferences

[at noodls] – LEXINGTON, Mass., Nov. 27, 2012 (GLOBE NEWSWIRE) — Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the … more

View todays social media effects on CRIS

View the latest stocks trending across Twitter. Click to view dashboard